|
于洪元醫師 Hung-Yuan Yu, M.D. |
||
學 位: |
陽明大學醫學士 |
||
現 職: |
臺北榮民總醫院內科部整合醫學科主治醫師 |
||
經歷: |
|
||
專長學科: |
|
||
專科證書: |
|
||
專科學會: |
|
||
通訊處: |
臺北市石牌路二段201號中正樓十二樓胃腸肝膽科 |
||
E-mail: |
Hyyu6@vghtpe.gov.tw |
||
重要著作: |
1. Hung-Yuan Yu, Chun-Yang Lee, Le-Gin Lin, Yee Chao, and Chung-Pin Li*. Nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy: A real-world experience. J Chin Med Assoc. 2022 Jan 1;85(1):42-50. doi: 10.1097/JCMA.0000000000000650. PMID: 34759212. (IF=2.743; Rank=62/167, Category = Medicine, General & Internal) 2. Hung-Yuan Yu, Chung-Pin Li, Yi-Hsiang Huang, Shao-Jung Hsu, Yen-Po Wang, Yun-Cheng Hsieh, Wen-Liang Fang, Kuo-Hung Huang, Anna Fen-Yau Li, Rheun-Chuan Lee, Kang-Lung Lee, Yuan-Hung Wu, I-Chun Lai, Wan-Chin Yang, Yi-Ping Hun, Yu-Chao Wang, Shu-Hui Chen, Ming-Huang Chen*, Yee Chao*. Microsatellite Instability, Epstein-Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer. Cancers (Basel). 2022 Jan 3;14(1):218. doi: 10.3390/cancers14010218. PMID: 35008382; PMCID: PMC8750088. (IF=6.639; Rank=51/242, Category = Oncology) |
最後更新: